Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.

The gut microbiota is a crucial actor in human physiology. Many of these effects are mediated by metabolites that are either produced by the microbes or derived from the transformation of environmental or host molecules. Among the array of metabolites at the interface between these microorganisms and the host is the essential aromatic amino acid tryptophan (Trp). In the gut, the three major Trp metabolism pathways leading to serotonin (5-hydroxytryptamine), kynurenine (Kyn), and indole derivatives are under the direct or indirect control of the microbiota. In this review, we gather the most recent advances concerning the central role of Trp metabolism in microbiota-host crosstalk in health and disease. Deciphering the complex equilibrium between these pathways will facilitate a better understanding of the pathogenesis of human diseases and open therapeutic opportunities.

[1]  Y. Li,et al.  Feedback Control of AHR Signaling Regulates Intestinal Immunity , 2017, Nature.

[2]  P. Scully,et al.  Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon‐gamma, severity of symptoms and psychiatric co‐morbidity , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[3]  W. Khan,et al.  Serotonin and GI Disorders: An Update on Clinical and Experimental Studies , 2012, Clinical and Translational Gastroenterology.

[4]  M. Chartrand,et al.  How important is tryptophan in human health? , 2019, Critical reviews in food science and nutrition.

[5]  Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions , 2016, Genome Medicine.

[6]  N. Kato,et al.  Association of Aryl Hydrocarbon Receptor-Related Gene Variants with the Severity of Autism Spectrum Disorders , 2016, Front. Psychiatry.

[7]  Thomas R. Ioerger,et al.  Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing , 2013, Cell.

[8]  J. Ruas,et al.  Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health , 2017, Science.

[9]  M. Fischbach,et al.  Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.

[10]  G. Sumara,et al.  Gut-derived serotonin is a multifunctional determinant to fasting adaptation. , 2012, Cell metabolism.

[11]  H. Fink,et al.  Serotonin controlling feeding and satiety , 2015, Behavioural Brain Research.

[12]  Y. Mine,et al.  l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. , 2010, The Journal of nutritional biochemistry.

[13]  T. Wood,et al.  Roles of indole as an interspecies and interkingdom signaling molecule. , 2015, Trends in microbiology.

[14]  A. De Luca,et al.  Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. , 2013, Immunity.

[15]  B. Bunting,et al.  Obesity, Whole Blood Serotonin and Sex Differences in Healthy Volunteers , 2012, Obesity Facts.

[16]  J. Sonnenburg,et al.  Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Oxenkrug Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways , 2013, Molecular Neurobiology.

[18]  R. Xavier,et al.  CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands , 2016, Nature Medicine.

[19]  C. Lim,et al.  Altered kynurenine pathway metabolism in autism: Implication for immune‐induced glutamatergic activity , 2016, Autism research : official journal of the International Society for Autism Research.

[20]  Daniel J. O'Connell,et al.  Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. , 2017, Cell host & microbe.

[21]  D. Macêdo,et al.  IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  K. Ryan,et al.  Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. , 2015, Chemistry & biology.

[23]  E. Lima,et al.  Dysregulation of Tryptophan Catabolism in Metabolic Syndrome. , 2018, Metabolic syndrome and related disorders.

[24]  Liang Zhou,et al.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. , 2012, Immunity.

[25]  B. Gu,et al.  Close association between intestinal microbiota and irritable bowel syndrome , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[26]  B. Balkau,et al.  The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation , 2015, Obesity.

[27]  N. Pochet,et al.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the aryl hydrocarbon receptor , 2016, Nature Medicine.

[28]  K. O'Farrell,et al.  Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders , 2017, Neuropharmacology.

[29]  P. Scully,et al.  The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner , 2013, Molecular Psychiatry.

[30]  Yulong Yin,et al.  Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism , 2018, Front. Cell. Infect. Microbiol..

[31]  J. Veenstra-VanderWeele,et al.  The serotonin system in autism spectrum disorder: From biomarker to animal models , 2016, Neuroscience.

[32]  J. Dyck,et al.  Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis , 2014, Nature Medicine.

[33]  Andrew H. Van Benschoten,et al.  Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. , 2014, Cell host & microbe.

[34]  J. Gordon,et al.  Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells , 2017, Science.

[35]  G. Nolan,et al.  A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites , 2017, Nature.

[36]  Ardiansyah,et al.  Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. , 2017, The Journal of nutritional biochemistry.

[37]  H. Sokol,et al.  Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. , 2015, Cell metabolism.

[38]  E. Campbell,et al.  Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor. , 2018, The American journal of pathology.

[39]  E. Elinav,et al.  Microbiome-Modulated Metabolites at the Interface of Host Immunity , 2017, The Journal of Immunology.

[40]  E. Quigley,et al.  Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. , 2014, World journal of gastroenterology.

[41]  G. Mawe,et al.  Non-conventional features of peripheral serotonin signalling — the gut and beyond , 2017, Nature Reviews Gastroenterology &Hepatology.

[42]  A. Rizzo,et al.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. , 2011, Gastroenterology.

[43]  Michael Krawczak,et al.  Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases. , 2017, Gastroenterology.

[44]  M. Samsom,et al.  SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[45]  D. Tarng,et al.  Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease , 2017, Journal of the American Heart Association.

[46]  J. Fichna,et al.  Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review. , 2017, Current drug targets.

[47]  U. Keyser,et al.  Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells , 2014, Cell reports.

[48]  M. Bellini,et al.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome , 2014, Techniques in Coloproctology.

[49]  T. Dinan,et al.  Kynurenine pathway metabolism and the microbiota-gut-brain axis , 2017, Neuropharmacology.

[50]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[51]  J. Galligan Beneficial actions of microbiota‐derived tryptophan metabolites , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[52]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[53]  T. Dinan,et al.  A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome , 2012, Front. Pharmacol..

[54]  T. Dinan,et al.  Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism , 2017, EBioMedicine.

[55]  Ryan D. Hernandez,et al.  Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism , 2013, Science Translational Medicine.

[56]  J. Mallet,et al.  Serotonin has a key role in pathogenesis of experimental colitis. , 2009, Gastroenterology.

[57]  H. Sokol,et al.  Aryl hydrocarbon receptor and intestinal immunity , 2018, Mucosal Immunology.

[58]  G. Perdew,et al.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation , 2015, Drug Metabolism and Disposition.